Article
Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association - 1 May 2020
Yap Desmond Y H, Tam Chun Hay, Yung Susan, Wong Sunny, Tang Colin S O, Mok Temy M Y, Yuen Catherine K Y, Ma Maggie K M, Lau Chak Sing, Chan Tak Mao
Abstract excerpt
BACKGROUND: There is little data on mycophenolic acid (MPA) pharmacokinetics and pharmacogenomics and optimal MPA exposure in lupus nephritis (LN) patients during long-term maintenance. METHODS: We measured blood MPA levels at 1, 2, 4, 8, 10 and 12-h post-dose (i.e. C1, C2, C4, C8, C10 and C12) in 88 stable LN patients receiving maintenance prednisolone and mycophenolate mofetil, repeated every 6 months. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
